Robert M. Rzasa

Total Synthesis and Immunosuppressive Activity of (−)-Pateamine A and Related Compounds:  Implementation of a β-Lactam-Based Macrocyclization

Daniel Romo, Robert M. Rzasa, Hélène A. Shea et al. · Journal of the American Chemical Society · 1998 · 149 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Novel Vanilloid Receptor-1 Antagonists:  2. Structure−Activity Relationships of 4-Oxopyrimidines Leading to the Selection of a Clinical Candidate

Elizabeth M. Doherty, Christopher Fotsch, Anthony W. Bannon et al. · Journal of Medicinal Chemistry · 2007 · 98 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Discovery and in Vivo Evaluation of (<i>S</i>)-<i>N</i>-(1-(7-Fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9<i>H</i>-purin-6-amine (AMG319) and Related PI3Kδ Inhibitors for Inflammation and Autoimmune Disease

Timothy D. Cushing, Xiaolin Hao, Youngsook Shin et al. · Journal of Medicinal Chemistry · 2014 · 86 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Palladium-Catalyzed Chemoselective Monoarylation of Hydrazides for the Synthesis of [1,2,4]Triazolo[4,3-<i>a</i>]pyridines

Andreas Reichelt, James R. Falsey, Robert M. Rzasa et al. · Organic Letters · 2010 · 78 citations

Natural Sciences, Chemistry, Medicinal Chemistry +14

Total Synthesis of the Novel, Immunosuppressive Agent (−)-Pateamine A from <i>Mycale </i>sp. Employing a β-Lactam-Based Macrocyclization

Robert M. Rzasa, Hélène A. Shea, Daniel Romo · Journal of the American Chemical Society · 1998 · 70 citations

Medicine, Medicinal Chemistry, Pharmacology +14